Filter by

Keywords

Congress

Year

abstract book

Access here all Abstracts accepted for oral and e-poster presentation at PCR London Valves 2018. You can browse by theme, topic or if you know what you are looking for, by author, title using the free search

Lond18A-OP002
Feasibility of analysis of a novel quantitative method to assess aortic regurgitation after TAVI: preliminary results of the ASSESS-REGURGE
ABDEL-WAHAB M. (1), SOLIMAN O. (2), ABDELGHANI M. (3), MODOLO R. (4), MIYAZAKI Y. (5), TATEICHI H. (6), CHANG C. C. (5), KOGAME N. (3), PIGHI M. (7), RAHHAB Z. (5), ONUMA Y. (2), PIAZZA N. (7), VAN MIEGHEM N. (5), SERRUYS P. (8)
(1) Segeberger Kliniken GmbH: Herzzentrum, Bad Segeberg GERMANY
(2) Erasmus MC / Cardialysis, Rotterdam / Rotterdam NETHERLANDS / NETHERLANDS
(3) Academic Medical Centre, Amsterdam NETHERLANDS
(4) Academic Medical Centre / UNICAMP Universidade Estadual de Campinas, Amsterdam / State of São Paulo NETHERLANDS / BRAZIL
(5) Erasmus MC, Rotterdam NETHERLANDS
(6) Yamaguchi University, Yamaguchi JAPAN
(7) McGill University, Montréal CANADA
(8) Imperial College London, London UNITED KINGDOM

+

Lond18A-OP003
Quantitative assessment of aortic regurgitation in seven different types of aortic valves after TAVI: a multicentre analysis by an independent core lab not sponsored by the industry
SERRUYS P. (1), MODOLO R. (2), MIYAZAKI Y. (3), CHANG C. C. (3), KOGAME N. (4), PIAZZA N. (5), PIGHI M. (5), ABDELGHANI M. (4), ABDEL-WAHAB M. (6), RAHHAB Z. (3), SOLIMAN O. (7), ONUMA Y. (7), TATEISHI H. (8), SANDOLI BRITO JR F. (8), LEMOS P. (8), VAN MIEGHEM N. (3)
(1) Imperial College London, London UNITED KINGDOM
(2) Academic Medical Centre / UNICAMP Universidade Estadual de Campinas, Amsterdam / State of São Paulo NETHERLANDS / BRAZIL
(3) Erasmus MC, Rotterdam NETHERLANDS
(4) Academic Medical Centre, Amsterdam NETHERLANDS
(5) McGill University, Montréal CANADA
(6) Segeberger Kliniken GmbH: Herzzentrum, Bad Segeberg GERMANY
(7) Erasmus MC / Cardialysis, Rotterdam / Rotterdam NETHERLANDS / NETHERLANDS
(8) Incor - Instituto do Coração do Hospital das Clínicas da FMUSP, State of São Paulo BRAZIL

+

Lond18A-OP005
Early outcomes comparison of TAVI using three different second-generation prostheses - Edwards SAPIEN 3, Medtronic Evolut R, Symetis ACURATE neo TF
COSTA G. (1), BUCCHERI S. (1), BARBANTI M. (1), TODARO D. (1), PICCI A. (1), DI SIMONE E. (1), D'ARRIGO P. (1), LA SPINA K. (1), CAPODANNO D. (1), TAMBURINO C. (1)
(1) Azienda Ospedaliero Universitaria Policlinico Vittorio Emanuele Presidio Ferrarotto, Catania ITALY

+

Lond18A-OP006
Comparison of transthoracic echocardiogram with quantitative assessment of aortic regurgitation after TAVI with videodensitometry in a large real-world population: sub-analysis of the RESPOND registry
MODOLO R. (1), SERRUYS P. (2), WORLE J. (3), HILDICK-SMITH D. (4), BLEIZIFFER S. (5), BLACKMAN D. (6), ABDEL-WAHAB M. (7), ALLOCCO D. (8), MEREDITH I. (8), ONUMA Y. (9), VAN MIEGHEM N. (10), SOLIMAN O. (9)
(1) Academic Medical Centre / UNICAMP Universidade Estadual de Campinas, Amsterdam / State of São Paulo NETHERLANDS / BRAZIL
(2) Imperial College London, London UNITED KINGDOM
(3) Ulm University, Ulm GERMANY
(4) Brighton & Sussex University Hospitals Nhs Trust, Brighton UNITED KINGDOM
(5) Deutsches Herzzentrum München - Klinik für Herz- und Gefäßchirurgie, Munich GERMANY
(6) Leeds General Infirmary, Leeds UNITED KINGDOM
(7) Segeberger Kliniken GmbH: Herzzentrum, Bad Segeberg GERMANY
(8) Boston Scientific Corporation, Marlborough UNITED STATES
(9) Erasmus MC / Cardialysis, Rotterdam / Rotterdam NETHERLANDS / NETHERLANDS
(10) Erasmus MC, Rotterdam NETHERLANDS

+

Lond18A-OP007
Hypo-attenuated leaflet thickening in surgically-implanted mitral bioprosthesis
HOSOBA S. (1), MORI M. (2), TSUNAKI T. (1), GOTO Y. (1), SHIMURA T. (1), YAMAMOTO M. (1)
(1) Toyohashi Heart Center, Toyohashi JAPAN
(2) Yale University, New Haven UNITED STATES

+

Lond18A-OP008
Early experience with the MitraClip XTR system for edge-to-edge repair of severe mitral regurgitation
BRAUN D. (1), HAUSLEITER J. (1), ORBAN M. (1), HAGL C. (1), MASSBERG S. (1), NABAUER M. (1)
(1) Klinikum der Universität München, Munich GERMANY

+

Lond18A-OP009
Myocardial strain before and after percutaneous mitral commissurotomy for severe mitral stenosis
SHAABAN R. (1)
(1) Ain Shams University Faculty of Medicine / Dar Al Fouad Hospital, Al Waili / 26th of July Corridor EGYPT / EGYPT

+

Lond18A-OP010
Impact of mitral valve pathology and MitraClip characteristics on mitral regurgitation after transcatheter mitral valve repair using MitraClip
ZAID S. (1), AHMAD H. (1), GOLDBERG J. (1), DUTTA T. (1), UNDEMIR C. (1), KAPLE R. (2), BENNETT J. (1), COHEN M. (1), LANSMAN S. (1), TANG G. (3)
(1) Westchester Medical Center, Valhalla UNITED STATES
(2) Yale University, New Haven UNITED STATES
(3) Mount Sinai Medical Center, New York UNITED STATES

+

Lond18A-OP011
Procedural to three-year outcomes of the MAVERIC CE mark trial of transcatheter annular reduction therapy for functional mitral regurgitation
REDWOOD S. (1)
(1) King's Health Partners, London UNITED KINGDOM

+

Lond18A-OP013
Transcarotid approach for TAVI with the SAPIEN 3 prosthesis: a multicentre French registry
OVERTCHOUK P. (1), MODINE T. (1)
(1) CHR LILLE, LILLE FRANCE

+

Lond18A-OP014
TAVI with the largest balloon-expandable vs. self-expanding valve in very large annuli: a multicentre study
TANG G. (1), GUPTA E. (1), ZAID S. (2), MAJEED F. (1), AHMAD H. (2), KHAN A. (1), KOVACIC J. (1), DANGAS G. (1), SHARMA S. (1), KINI A. (1)
(1) Mount Sinai Medical Center, New York UNITED STATES
(2) Westchester Medical Center, Valhalla UNITED STATES

+

Lond18A-OP015
Left ventricular outflow tract seal zone geometry "non-tubular index" predicts new persistent left bundle branch block after Edwards SAPIEN 3 but not Medtronic Evolut R TAVI
ZAID S. (1), BRINKERT M. (2), AHMAD H. (1), KAPLE R. (3), LANSMAN S. (1), DANGAS G. (4), SHARMA S. (4), KINI A. (4), TOGGWEILER S. (2), TANG G. (4)
(1) Westchester Medical Center, Valhalla UNITED STATES
(2) Luzerner Kantonsspital Luzern, Luzern SWITZERLAND
(3) Yale University, New Haven UNITED STATES
(4) Mount Sinai Medical Center, New York UNITED STATES

+

Lond18A-OP016
Transcatheter mitral valve repair in patients with functional mitral regurgitation: results from the multicentre trial - Two-year interim outcomes
MAISANO F. (1), NICKENIG G. (2), JULIARD J. M. (3), COLOMBO A. (4), ALFIERI O. (4), LATIB A. (4), KUCK K. H. (5), BALDUS S. (6), VON BARDELEBEN R. S. (7), VAN DER HEIJDEN J. (8), KERNER A. (9), TAMBURINO C. (10), HAUSLEITER J. (11), VAHANIAN A. (3)
(1) University Hospital of Zürich, Zürich SWITZERLAND
(2) University Hospital Bonn, Bonn GERMANY
(3) HU PARIS NORD SITE BICHAT APHP, PARIS FRANCE
(4) San Raffaele Hospital, Milano ITALY
(5) Asklepios Klinik Sankt Georg, Hamburg GERMANY
(6) University of Cologne Heart Center, Cologne GERMANY
(7) Universitätsmedizin Mainz, Mainz GERMANY
(8) St. Antonius Hospital, Nieuwegein NETHERLANDS
(9) Rambam Medical Center, Haifa ISRAEL
(10) Policlinico Vittorio Emanuele University Hospital , University of Catania, , Catania ITALY
(11) Ludwig-Maximilians-Universität München, Munich GERMANY

+

Lond18A-OP018
Commissural misalignment and interference with coronary orifices from transcatheter heart valves: impact of neo-commissures on coronary access after TAVI
TANG G. (1), ZAID S. (2), AHMAD H. (2), KAPLE R. (3), UNDEMIR C. (2), COHEN M. (2), LANSMAN S. (2)
(1) Mount Sinai Medical Center, New York UNITED STATES
(2) Westchester Medical Center, Valhalla UNITED STATES
(3) Yale School of Medicine, New Haven UNITED STATES

+

Lond18A-OP019
First direct comparison of the self-expandable Portico vs. the balloon-expandable SAPIEN 3 device for TAVR: a case-matched cohort study
MAS-PEIRO S. (1), WEILER H. (1), MOHR G. L. (1), PAPADOPOULOS N. (1), ZEIHER A. M. (1), FICHTLSCHERER S. (1), VASA-NICOTERA M. (1)
(1) Universitätsklinikum Frankfurt, Frankfurt am Main GERMANY

+

Lond18A-OP020
One-year outcomes with the transcatheter LOTUS Edge aortic valve system
GöTBERG M. (1), BLEIZIFFER S. (2), GOOLEY R. (3), WALTERS D. L. (4), SONDERGAARD L. (5), DUMONTEIL N. (6), ALLOCCO D. (7), MEREDITH I. (7)
(1) Skane University Hospital, Lund SWEDEN
(2) Deutsches Herzzentrum München, Technische Universität München, Munich GERMANY
(3) MonashHeart, Clayton AUSTRALIA
(4) The Prince Charles Hospital, Chermside West AUSTRALIA
(5) Rigshospitalet, København DENMARK
(6) CLINIQUE PASTEUR, TOULOUSE FRANCE
(7) Boston Scientific Corporation, Marlborough, MA UNITED STATES

+

Lond18A-OP021
TAVI for severe aortic valve stenosis with the ACURATE neo2 valve system: 30-day safety and performance outcomes
MOELLMANN H. (1), HOLZHEY D. M. (2), HILKER M. (3), TOGGWEILER S. (4), SCHäFER U. (5), TREEDE H. (6), JONER M. (7), SONDERGAARD L. (8), CHRISTEN T. (9), MEREDITH I. (9), KIM W. K. (10)
(1) St.-Johannes-Hospital, Dortmund GERMANY
(2) Heart Center Leipzig GmbH, Leipzig GERMANY
(3) Universität Regensburg, Regensburg GERMANY
(4) Luzerner Kantonsspital Luzern, Luzern SWITZERLAND
(5) University Medical Center Hamburg-Eppendorf- UKE, Hamburg GERMANY
(6) Universitätsklinikum Halle (Saale), Halle (Saale) GERMANY
(7) German Heart Centre Munich / Deutsches Herzzentrum München, Munich GERMANY
(8) Rigshospitalet, København DENMARK
(9) Boston Scientific Corporation, Marlborough UNITED STATES
(10) Kerckhoff Heart Centre, Bad Nauheim GERMANY

+

Lond18A-OP022
Four-year outcomes with a fully repositionable and retrievable percutaneous aortic valve in 250 high surgical risk patients: results from the REPRISE II trial extended cohort
BLACKMAN D. (1), DUMONTEIL N. (2), TCHéTCHé D. (2), HILDICK-SMITH D. (3), MANOHARAN G. (4), WALTERS D. L. (5), HARNEK J. (6), WORTHLEY S. (7), RIOUFOL G. (8), ALLOCCO D. (9), MEREDITH I. (9)
(1) Leeds General Infirmary, Leeds UNITED KINGDOM
(2) CLINIQUE PASTEUR, TOULOUSE FRANCE
(3) Sussex Cardiac Centre, Brighton and Sussex University Hospitals, Brighton UNITED KINGDOM
(4) Royal Victoria Hospital, Belfast UNITED KINGDOM
(5) The Prince Charles Hospital, Chermside West AUSTRALIA
(6) University Hospital of Lund, Lund SWEDEN
(7) Royal Adelaide Hospital, Adelaide AUSTRALIA
(8) Hôpital Cardiologique de Lyon, Hospices Civils de Lyon, Bron FRANCE
(9) Boston Scientific Corporation, Marlborough, MA UNITED STATES

+

Lond18A-OP024
Single-centre initial experience with mitral annuloplasty using Carillon device for patients with significant mitral regurgitation and left ventricular dysfunction
SCALISE F. (1), GURBHEJ S. (1), SINGH G. (1), SORROPAGO G. (1), VALENTI G. (1), SORROPAGO A. (1), ABETE R. (1), MAZZETTI S. (1), ROSSI J. (1), SANTAMBROGIO C. A. (1), MORTARA A. (1)
(1) Policlinico di Monza, Monza ITALY

+

Lond18A-OP025
Fusion aortic valve area: is it a reliable imaging method in symptomatic patients with severe aortic stenosis?
VAVURANAKIS Ma. (1), DRIS E. (1), KARIORI M. (1), KALOGERAS K. (1), SIASOS G. (1), KALANTZIS C. (1), BEI E. (1), KOLOKATHIS A. (1), MOLDOVAN C. M. (1), OIKONOMOU E. (1), TOUSOULIS D. (1)
(1) National and Kapodistrian University of Athens, Athens GREECE

+

Lond18A-OP027
Prognostic impact of calcium score after TAVI performed with new-generation prosthesis
AKODAD M. (1), LATTUCA B. (1), AGULLO A. (1), MACIA J. C. (1), GANDET T. (1), MARIN G. (1), SCHMUTZ L. (1), NAGOT N. (1), ALBAT B. (1), CAYLA G. (1), LECLERCQ F. (1)
(1) HOPITAL ARNAUD DE VILLENEUVE CHU MPT, MONTPELLIER FRANCE

+

Lond18A-POS002
Hemodynamic changes after transcatheter tricuspid valve repair in patients with severe tricuspid regurgitation and right-sided heart failure
ORBAN M. (1), BRAUN D. (1), STOCKER T. (1), MASSBERG S. (1), NABAUER M. (1), HAUSLEITER J. (1)
(1) Klinikum der Universität München, Munich GERMANY

+

Lond18A-POS003
3D printed cardiac model for improving consent process in patients referred for TAVI
GRODECKI K. (1), HUCZEK Z. (1), RYMUZA B. (1), ZBRONSKI K. (1), SCISLO P. (1), KOPER D. (1), WILIMSKI R. (1), KOCHMAN J. (1), FILIPIAK K. J. (1), OPOLSKI G. (1)
(1) Medical University of Warsaw, Warszawa POLAND

+

Lond18A-POS004
Self-positioning transseptal puncture-and-guidance steerable system: changing the paradigm in left atrial interventions
TARAMASSO M. (1), ROSSER B. (1), POZZOLI A. (1), METZNER A. (2), VAHANIAN A. (3), KUCK K. H. (2), MAISANO F. (1)
(1) University Hospital of Zürich, Zürich SWITZERLAND
(2) Asklepios Kliniken Hamburg GmbH, Hamburg GERMANY
(3) HU PARIS NORD SITE BICHAT APHP, PARIS FRANCE

+

Lond18A-POS005
Evaluating a novel tri-fold expandable 14Fr vascular sheath for self-expanding TAVI valves - First-in-man experience
MICHEL J. (1), DEUTSCH O. (1), JONER M. (1), PELLEGRINI C. (1), RHEUDE T. (1), ALVAREZ H. (1), FRANGIEH A. (1), MAYR N. P. (1), XHEPA E. (1), KASEL A. M. (1)
(1) German Heart Centre Munich / Deutsches Herzzentrum München, Munich GERMANY

+

Lond18A-POS006
Comparison of rates of pacemaker implantation between balloon-expandable and self-expanding transcatheter aortic valve prostheses
BRENNAN A. (1), HENNESSEY B. (1), FITZPATRICK N. (1), YEAROO I. (1), KERR B. (1), ALI M. (1), MAREE A. (1), FOLEY B. (1), CREAN P. (1), O'CONNOR S. (1)
(1) St. James's Hospital, Dublin 8 IRELAND

+

Lond18A-POS007
Improvement of cardiac output and daily physical activity after percutaneous repair of severe tricuspid regurgitation
STOCKER T. (1), ORBAN M. (1), BRAUN D. (1), SCHECK F. (1), DESEIVE S. (1), WECKBACH L. (1), ENGELMAIR A. (1), NABAUER M. (1), MASSBERG S. (1), HAUSLEITER J. (1)
(1) Medizinische Klinik und Poliklinik I, Klinikum der Universität, Ludwig-Maximilians-Universität Munich, Munich GERMANY

+

Lond18A-POS008
Safety and feasibility of percutaneous plug-based arteriotomy closure device in TAVI procedure. Initial experience
GHEORGHE L. (1), BROUWER J. (1), NIJENHUIS V. (1), RENSING B. (1), TEN BERG J. (1), HEIJMEN R. (1), DE KROON R. (1), SWAANS M. (1), VAN DER HEIJDEN J. (1)
(1) St. Antonius Hospital, Nieuwegein NETHERLANDS

+

Lond18A-POS010
The role of quantitative videodensitometry aortographic assessment of aortic regurgitation in the guidance of TAVI
MODOLO R. (1), MIYAZAKI Y. (2), ABDELGHANI M. (3), CHICHAREON P. (4), TATEISHI H. (5), KATAGIRI Y. (4), ASANO T. (4), SARMENTO-LEITE R. (6), MANGIONE J. (7), ABIZAID A. (8), SOLIMAN O. (9), ONUMA Y. (9), SERRUYS P. (10), LEMOS P. (11), SANDOLI BRITO JR F. (11)
(1) Academic Medical Centre / UNICAMP Universidade Estadual de Campinas, Amsterdam / State of São Paulo NETHERLANDS / BRAZIL
(2) Erasmus MC / Yamaguchi University, Rotterdam / Yamaguchi NETHERLANDS / JAPAN
(3) Academic Medical Centre / Segeberger Kliniken GmbH: Herzzentrum, Amsterdam / Bad Segeberg NETHERLANDS / GERMANY
(4) Academic Medical Centre, Amsterdam NETHERLANDS
(5) Yamaguchi University, Yamaguchi JAPAN
(6) Instituto de Cardiologia, RS BRAZIL
(7) Beneficência Portuguesa, State of São Paulo BRAZIL
(8) Instituto Dante Pazzanese, State of São Paulo BRAZIL
(9) Erasmus MC / Cardialysis, Rotterdam / Rotterdam NETHERLANDS / NETHERLANDS
(10) Imperial College London, London UNITED KINGDOM
(11) Incor - Instituto do Coração do Hospital das Clínicas da FMUSP, State of São Paulo BRAZIL

+

Lond18A-POS011
Clinical validation of a novel software for retrospective quantitative assessment of FFR in TAVI patients
KOOISTRA N. (1), NIJHOFF F. (1), VOSKUIL M. (1), KRAAIJEVELD A. (1), STELLA P. (1)
(1) UMC, Utrecht NETHERLANDS

+

Lond18A-POS012
TAVI for degenerative surgical bioprosthesis: single-centre valve-in-valve five-year experience
WALEED M. (1), SARAF S. (1), ALI N. (1), CUNNINGTON M. (1), BLACKMAN D. (1), MALKIN C. (1)
(1) Leeds General Infirmary, Leeds UNITED KINGDOM

+

Lond18A-POS013
Completion of inter-technique comparison of intra-procedural post-TAVI aortic regurgitation assessments
TATEISHI H. (1), OKAMURA T. (1), MIYAZAKI Y. (1), WADA Y. (1), OKUDA S. (1), OMURO A. (1), HAMADA Y. (1), ARIYOSHI T. (1), FUJII A. (1), ODA T. (1), YANO M. (1)
(1) Yamaguchi University, Yamaguchi JAPAN

+

Lond18A-POS014
Are we ready for first-in-man? The big step from pre-clinical to patients
ROSSER B. (1), GUIDOTTI A. (1), VICENTINI L. (1), CESAROVIC N. (1), MAISANO F. (1)
(1) University of Zurich, Zürich SWITZERLAND

+

Lond18A-POS015
Nonagenarians with severe aortic stenosis have comparable mortality outcomes at one year compared to non-nonagenarians with severe aortic stenosis, post-TAVR
RANDHAWA M. (1), SALEH Y. (2), HERZALLAH K. (2), CHO N. (3), BAUMGARTNER N. (4), DHAR G. (1)
(1) Michigan State University / Sparrow Hospital / Sparrow Clinical Research Institute, East Lansing / Lansing / Lansing UNITED STATES / UNITED STATES / UNITED STATES
(2) Michigan State University / Sparrow Hospital, East Lansing / Lansing UNITED STATES / UNITED STATES
(3) Sparrow Hospital / Sparrow Clinical Research Institute, Lansing / Lansing UNITED STATES / UNITED STATES
(4) Sparrow Hospital, Lansing UNITED STATES

+

Lond18A-POS016
Impact of transcatheter tricuspid valve repair on right ventricular dimension and function in patients with severe tricuspid regurgitation
ORBAN M. (1), BRAUN D. (1), MASSBERG S. (1), NABAUER M. (1), HAUSLEITER J. (1)
(1) Klinikum der Universität München, Munich GERMANY

+

Lond18A-POS018
Quantification of stent creep by three-dimensional transoesophageal echocardiography in patients undergoing transcatheter aortic valve-in-valve implantation for failed bioprostheses
HUANG K. C. (1), LEE Y. T. (1), WEI J. (1), YIN W. H. (1)
(1) Cheng Hsin General Hospital, Taipei City TAIWAN

+

Lond18A-POS019
Are high-intensity transient signals detected by transcranial doppler during TAVI related to platelet inhibition?
VAVURANAKIS Ma. (1), KALANTZIS C. (1), VAVURANAKIS Mi. (1), KARIORI M. (1), VOUDRIS V. (2), TOUTOUZAS K. (1), KALOGERAS K. (1), MOLDOVAN C. M. (1), SIASOS G. (1), TOUSOULIS D. (1)
(1) "Ippokrateio" General Hospital of Athens, Athina GREECE
(2) Onassis Cardiac Surgery Center, Kallithea GREECE

+

Lond18A-POS020
Contemporary frequency and management of bicuspid aortic valves in symptomatic aortic valve disease patients: the BiTri registry
BROCHADO B. (1), BLEIZIFFER S. (2), DE BACKER O. (3), BERTHOUMIEU P. (4), VAN MIEGHEM N. (5), CARVALHO H. (6), SAINT ETIENNE C. (7), LESCOT B. (4), DE BIASE C. (4), TCHETCHE D. (4)
(1) CLINIQUE PASTEUR / Centro Hospitalar do Porto, TOULOUSE / Porto FRANCE / PORTUGAL
(2) German Heart Centre Munich / Deutsches Herzzentrum München, Munich GERMANY
(3) Rigshospitalet, København DENMARK
(4) CLINIQUE PASTEUR, TOULOUSE FRANCE
(5) Erasmus MC, Rotterdam NETHERLANDS
(6) Centro Hospitalar do Porto, Porto PORTUGAL
(7) CHRU TROUSSEAU - CHAMBRAY, CHAMBRAY LES TOURS FRANCE

+

Lond18A-POS021
Drug-related platelet inhibition and embolic high-intensity transient signals during TAVI
VAVURANAKIS Ma. (1), VAVURANAKIS Mi. (1), KALANTZIS C. (1), KARIORI M. (1), VOUDRIS V. (2), TOUTOUZAS K. (1), KOSMAS E. (2), KALOGERAS K. (1), BEI E. (1), TOUSOULIS D. (1)
(1) "Ippokrateio" General Hospital of Athens, Athina GREECE
(2) Onassis Cardiac Surgery Center, Kallithea GREECE

+

Lond18A-POS022
Mild aortic regurgitation after TAVI: how mild is truly mild?
ABDUL HAMID A. (1), ASHARI A. (1)
(1) Institut Jantung Negara Sdn Bhd, Kuala Lumpur MALAYSIA

+

Lond18A-POS023
Quantitative assessment of acute regurgitation after TAVI: comparison of first and second-generation valves
MODOLO R. (1), RODRIGO M. (1), MIYAZAKI Y. (2), TATEISHI H. (3), PIAZZA N. (4), PIGHI M. (5), CHANG C. C. (2), KOGAME N. (6), ABDELGHANI M. (7), SOLIMAN O. (8), ONUMA Y. (8), SANDOLI BRITO JR F. (9), LEMOS P. (10), ABDEL-WAHAB M. (11), RAHHAB Z. (12), VAN MIEGHEM N. (2), SERRUYS P. (13)
(1) Academic Medical Centre / UNICAMP Universidade Estadual de Campinas, Amsterdam / State of São Paulo NETHERLANDS / BRAZIL
(2) Erasmus MC, Rotterdam NETHERLANDS
(3) Yamaguchi University, Yamaguchi JAPAN
(4) McGill University, Montréal CANADA
(5) Yamaguchi University / McGill University, Yamaguchi / Montréal JAPAN / CANADA
(6) Academic Medical Centre, Amsterdam NETHERLANDS
(7) Academic Medical Centre / Segeberger Kliniken GmbH: Herzzentrum, Amsterdam / Bad Segeberg NETHERLANDS / GERMANY
(8) Erasmus MC / Cardialysis, Rotterdam / Rotterdam NETHERLANDS / NETHERLANDS
(9) McGill University / Incor - Instituto do Coração do Hospital das Clínicas da FMUSP, Montréal / State of São Paulo CANADA / BRAZIL
(10) Erasmus MC / Incor - Instituto do Coração do Hospital das Clínicas da FMUSP, Rotterdam / State of São Paulo NETHERLANDS / BRAZIL
(11) Segeberger Kliniken GmbH: Herzzentrum, Bad Segeberg GERMANY
(12) Erasmus MC / Imperial College London, Rotterdam / London NETHERLANDS / UNITED KINGDOM
(13) Imperial College London, London UNITED KINGDOM

+

Lond18A-POS024
Changes in platelet reactivity during TAVI
OSTOJIC Z. (1), BULUM J. (1), STROZZI M. (1), SAFRADIN I. (1), RESKOVIC LUKSIC V. (1), SEPAROVIC HANZEVACKI J. (1), SAMARDZIC J. (1), PAVASOVIC S. (1), MILICIC D. (1), BIOCINA B. (1)
(1) University hospital center Zagreb, Zagreb CROATIA

+

Lond18A-POS025
Infective endocarditis after TAVI: contributions of a single-centre experience on incidence and associated factors
LOPEZ MINGUEZ J. R. (1), NOGALES-ASENSIO J. M. (1), FRANCISCO FéLIX R. V. (1), CALVO-CANO A. (1), GóMEZ-SANCHEZ I. (1), MARTíNEZ-CARAPETO A. (1), BENGLA-LIMPO B. (1), VERA-TOMé A. (1), GONZáLEZ-FERNáNDEZ R. (1), MERCHáN-HERRERA A. (1)
(1) Hospital Universitario Infanta Cristina, Badajoz SPAIN

+

Lond18A-POS028
Left ventricular outflow tract seal zone geometry "non-tubular index" predicts new permanent pacemaker implantation after Medtronic Evolut R but not Edwards SAPIEN 3 TAVI
ZAID S. (1), BRINKERT M. (2), AHMAD H. (1), KAPLE R. (3), LANSMAN S. (1), DANGAS G. (4), SHARMA S. (4), KINI A. (4), TOGGWEILER S. (2), TANG G. (4)
(1) Westchester Medical Center, Valhalla UNITED STATES
(2) Luzerner Kantonsspital Luzern, Luzern SWITZERLAND
(3) Yale University, New Haven UNITED STATES
(4) Mount Sinai Medical Center, New York UNITED STATES

+

Lond18A-POS029
Coronary procedures after TAVR with self-expandable valves vs. balloon-expandable valves
YIN W. H. (1), TSAO T. P. (1), WEI J. (1)
(1) Cheng Hsin General Hospital, Taipei City TAIWAN

+

Lond18A-POS030
Mitral annulus and left atrial anatomical changes after transcatheter mitral valve repair
ALPERI A. (1), PASCUAL CALLEJA I. (1), ARGüERO LEóN V. (1), PADRON ENCALADA R. (1), SILVA CONDE I. (1), DIAZ MENDEZ R. (1), HERNANDEZ-VAQUERO D. (1), DE LA HERA GALARZA J. M. (1), AVANZAS P. (1), MORIS C. (1)
(1) Hospital Universitario Central De Asturias, Oviedo SPAIN

+

Lond18A-POS031
Clinical experience with a new fully absorbable patch-based large hole vascular closure device
MARTIN C. (1)
(1) St. James's Hospital, Dublin 8 IRELAND

+

Lond18A-POS032
Early improvement of mitral regurgitation severity in patients who underwent TAVR with a self-expandable valve is a predictor of better late survival
LEE Y. T. (1), HSIUNG M. C. (1), YIN W. H. (1), WEI J. (1)
(1) Cheng Hsin General Hospital, Taipei City TAIWAN

+

Lond18A-POS033
Comparison of percutaneous approach vs. surgical cutdown in Japanese patients undergoing transfemoral TAVI
KONO H. (1), EHARA N. (1), HORITA R. (1), KIM K. (1), OTA M. (1), KITAI T. (1), YAMANE T. (1), KINOSHITA M. (1), KAJI S. (1), KOYAMA T. (1), FURUKAWA Y. (1)
(1) Kobe City Medical Center General Hospital, Kobe-shi JAPAN

+

Lond18A-POS034
Commissure-to-commissure alignment of aortic bioprosthesis and native aortic valve following surgical and TAVR and its impact on valvular function
DE BACKER O. (1), FUCHS A. (1), YOON S. H. (2), MAKKAR R. (2), KOFOED K. F. (1), SONDERGAARD L. (1), BAPAT V. (3)
(1) Rigshospitalet, København DENMARK
(2) Cedars-Sinai Medical Center, Los Angeles UNITED STATES
(3) Columbia University, New York UNITED STATES

+

Loading...